Sofinnova Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History

Sofinnova Investments’s Portfolio AMLX Stock Details AMLX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6.37M	Buy
2024 Q3	–	Sell
2024 Q2	$569K	Sell
2024 Q1	$871K	Buy
2022 Q3	–	Sell
2022 Q2	$3.61M	Buy
2022 Q1	$1.28M	Buy